Sarah Meeks, PhD
About Sarah Meeks, PhD
Sarah Meeks, PhD, serves as the Senior Vice President of Business Development at MaxCyte, Inc., a position she has held since 2019. With extensive experience in the biotech sector, she has held various leadership roles and possesses a strong background in biochemistry, regenerative medicine, and business development.
Work at MaxCyte, Inc.
Sarah Meeks serves as the Senior Vice President of Business Development at MaxCyte, Inc. since 2019. In this role, she focuses on advancing the company's business strategies and partnerships within the biotech sector. Her leadership is instrumental in driving growth and fostering collaborations that enhance MaxCyte's position in the market.
Previous Experience at Synpromics Ltd
Prior to her current position, Sarah Meeks held the role of Vice President of Business Development at Synpromics Ltd from 2016 to 2019. During her tenure, she contributed to the company's strategic initiatives and played a key role in expanding its business operations in the synthetic biology field.
Education and Expertise
Sarah Meeks earned her PhD in Biochemistry, Molecular Biology, and Bioethics from the University of Minnesota, where she studied from 1989 to 1994. She also holds a BS in Biochemistry from the University of Wisconsin, completed in 1988. Additionally, she pursued continued education in business administration at The Wharton School in 2000. Her academic background complements her extensive expertise in stem cell technologies, regenerative medicine, and gene therapy.
Background in Business Development
Throughout her career, Sarah Meeks has held various leadership positions in business development within the biotech and healthcare sectors. She served as Vice President of Pharmaceutical Business Development at Orasi Medical from 2009 to 2011 and was the Chief Scientific Officer at Adjuvant Partners from 2012 to 2019. Her roles have consistently involved strategic planning and execution in emerging technologies.
Achievements in Regenerative Medicine
Sarah Meeks has a notable background in regenerative medicine, having worked as Director of the Tissue Engineering and Biomaterials Section at the Alliance for Regenerative Medicine from 2012 to 2018. She also directed the Gene Therapy Section during the same period. Her work has contributed to advancements in the field and the commercialization of innovative technologies.